Spironolactone for Pulmonary Arterial Hypertension

Clinical trial NCT01712620 · RECRUITING

Trial details

NCT number: NCT01712620
Sponsor: National Institutes of Health Clinical Center (CC)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2014-01-10
Primary completion: 2026-12-31
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.